Publication

Algotar A, Hsu C-H, Sherry Chow HH, Dougherty S, Babiker HM, Marrero D, Abraham I, Kumar R, Ligibel J, Courneya KS, et al. 2019. Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP): Protocol for a Feasibility and Exploratory Efficacy Study in Men on Androgen Deprivation Therapy. JMIR Res Protoc. 8:e12579. doi:10.2196/12579.

Witten ML, Chau B, Sáez E, Boitano S, Clark Lantz R. 2019. Early life inhalation exposure to mine tailings dust affects lung development. Toxicol Appl Pharmacol. 365:124–132. doi:10.1016/j.taap.2019.01.009.

Liang J, Wolsiefer K, Zestcott CA, Chase D, Stone J. 2019 Feb. Implicit bias toward cervical cancer: Provider and training differences. Gynecol Oncol. doi:10.1016/j.ygyno.2019.01.013.

Chipollini J, Garcia-Castaneda J, Rosa AHD la, Cheriyan S, Azizi M, Spiess PE. 2019 Feb. Important surgical concepts and techniques in inguinal lymph node dissection. Curr Opin Urol. doi:10.1097/MOU.0000000000000591.

Thompson HL, Smithey MJ, Uhrlaub JL, Jeftić I, Jergović M, White SE, Currier N, Lang AM, Okoye A, Park B, et al. 2019. Lymph nodes as barriers to T-cell rejuvenation in aging mice and nonhuman primates. Aging Cell. 18:e12865. doi:10.1111/acel.12865.

Sullivan A, Wallace RL, Wellington R, Luo X, Capaldi AP. 2019. Multilayered regulation of TORC1-body formation in budding yeast. Luo K, editor. Molecular Biology of the Cell. 30(3):400–410. doi:10.1091/mbc.e18-05-0297.

Hennemeyer C, Khan A, McGregor H, Moffett C, Woodhead G. 2019. Outcomes of Catheter-Directed Therapy Plus Anticoagulation Versus Anticoagulation Alone for Submassive and Massive Pulmonary Embolism. Am J Med. 132:240–246. doi:10.1016/j.amjmed.2018.10.015.

Mandava S, Keerthivasan MB, Martin DR, Altbach MI, Bilgin A. 2019 Feb. Radial streak artifact reduction using phased array beamforming. Magn Reson Med. doi:10.1002/mrm.27689.

Lin KK, Harrell MI, Oza AM, Oaknin A, Ray-Coquard I, Tinker AV, Helman E, Radke MR, Say C, Vo L-T, et al. 2019. Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma. Cancer Discov. 9:210–219. doi:10.1158/2159-8290.CD-18-0715.

Chandana S, Babiker HM, Mahadevan D. 2019. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC). Expert Opin Investig Drugs. 28:161–177. doi:10.1080/13543784.2019.1557145.

Kozák L, Szilágyi Z, Tóth L, Pócsi I, Molnár I. 2019. Tremorgenic and neurotoxic paspaline-derived indole-diterpenes: biosynthetic diversity, threats and applications. Appl Microbiol Biotechnol. 103:1599–1616. doi:10.1007/s00253-018-09594-x.

Romagnolo DF, Donovan MG, Doetschman TC, Selmin OI. 2019. -6 Linoleic Acid Induces Epigenetics Alterations Associated with Colonic Inflammation and Cancer. Nutrients. 11. doi:10.3390/nu11010171.

Garcia DO, Valdez LA, Aceves B, Bell ML, Humphrey K, Hingle M, McEwen M, Hooker SP. 2019. A Gender- and Culturally Sensitive Weight Loss Intervention for Hispanic Men: Results From the Pilot Randomized Controlled Trial. Health Educ Behav. 46:763–772. doi:10.1177/1090198119853011.

Truong DD, Kratz A, Park JG, Barrientos ES, Saini H, Nguyen T, Pockaj B, Mouneimne G, LaBaer J, Nikkhah M. 2019. A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells. Cancer Res. 79:3139–3151. doi:10.1158/0008-5472.CAN-18-2293.

Wang M, Knudsen BS, Nagle RB, Rogers GC, Cress AE. 2019 Jan. A method to quantify centrosomes at single-cell level in human normal and cancer tissue. Mol Biol Cell.:mbcE18100651. doi:10.1091/mbc.E18-10-0651.

Segar JM, Reed D, Stopeck A, Livingston RB, Chalasani P. 2019. A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer. Oncologist. 24:1512-e1267. doi:10.1634/theoncologist.2019-0516.

Alnajjar KS, Krylov IS, Negahbani A, Haratipour P, Kashemirov BA, Huang J, Mahmoud M, McKenna CE, Goodman MF, Sweasy JB. 2019. A pre-catalytic non-covalent step governs DNA polymerase β fidelity. Nucleic Acids Res. 47:11839–11849. doi:10.1093/nar/gkz1076.

Weihs KL, McConnell MH, Wiley JF, Crespi CM, Sauer-Zavala S, Stanton AL. 2019. A preventive intervention to modify depression risk targets after breast cancer diagnosis: Design and single-arm pilot study. Psychooncology. 28:880–887. doi:10.1002/pon.5037.

Shroff RT, Kennedy EB, Bachini M, Bekaii-Saab T, Crane C, Edeline J, El-Khoueiry A, Feng M, Katz MHG, Primrose J, et al. 2019. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. J Clin Oncol. 37:1015–1027. doi:10.1200/JCO.18.02178.

Collins-McMillen D, Rak M, Buehler JC, Igarashi-Hayes S, Kamil JP, Moorman NJ, Goodrum F. 2019. Alternative promoters drive human cytomegalovirus reactivation from latency. Proc Natl Acad Sci U S A. 116:17492–17497. doi:10.1073/pnas.1900783116.

Gachupin FC, Garcia CA, Romero MD. 2019. An American Indian Patient Experience. J Health Care Poor Underserved. 30:62–65. doi:10.1353/hpu.2019.0116.

Steele NG, Chakrabarti J, Wang J, Biesiada J, Holokai L, Chang J, Nowacki LM, Hawkins J, Mahe M, Sundaram N, et al. 2019. An Organoid-Based Preclinical Model of Human Gastric Cancer. Cell Mol Gastroenterol Hepatol. 7:161–184. doi:10.1016/j.jcmgh.2018.09.008.

Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, et al. 2019. Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Cancer. 125:18–44. doi:10.1002/cncr.31719.

Nfonsam VN, Nfonsam LE, Chen D, Omesiete PN, Cruz A, Runyan RB, Jandova J. 2019. COMP Gene Coexpresses With EMT Genes and Is Associated With Poor Survival in Colon Cancer Patients. J Surg Res. 233:297–303. doi:10.1016/j.jss.2018.08.021.

Kunihiro AG, Brickey JA, Frye JB, Luis PB, Schneider C, Funk JL. 2019. Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGFβ-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues. J Nutr Biochem. 63:150–156. doi:10.1016/j.jnutbio.2018.09.021.